Biology

sorry, I should say on that one, is that many other people are saying this.

So even critics like Michael Mann, who would just reject my work out of hand in the past, he's now put his name to the... uh 2026 world climate update with other top scientists and they say that we're already in a catastrophic situation which is beyond our ability to respond i could even find the quote here we are witnessing the rapid destabilization of the earth's climate system this is no longer a warning for the future it is a diagnosis of the present with changes unfolding faster than our ability to respond That was in Bioscience.

That's from the paper, not from Michael's lips directly.

He signed on to the paper.

I'm Daniel Levine, and this is the BioReport.

Biotech investors have long considered scientific uncertainty, clinical setbacks, and commercial risk when making investments.

John Stanford, founder and executive director of the policy advocacy organization Incubate, argues that the life sciences venture capital firms he represents... need to pay increasing attention to Washington due to instability at the U.S. Food and Drug Administration, competitive threats from China's emergence as an innovation powerhouse, and reduced federal investment in research.

Stanford discusses how drug pricing policy and FDA leadership turnover influence which companies get funded.

And while there are odd examples like Belisarius Call, few have had the political capital to be able to make any true explorations of what humanity might be capable of.

Such restrictions, though, are in fact not without good reason, for the Mechanicus well understands that to experiment with long-lost knowledge, Xenos Tech offer those within the Biologis explorations of genetics, not to mention dark concepts that exist as being akin to magic from the perception of those within the broader Imperium.

It all adds up to the idea of a rogue Mechanicus or human scientist tinkering around with things that they do not fully understand being generally quite a bad idea, and that yes, whilst this may enable some leaps forward and advancement, it's often quite evident that given the power of what could potentially be unleashed, the Mechanicus follow their rules of experimentation for good reason.

And to those who would say otherwise, case in point, one Magos Biologis Homeartis of the Adeptus Mechanicus, and his misadventures upon Necromunda and Hive Secundus.

Throughout the vast, sprawling Empire of Humanity in M41, Hive Worlds continue to stand witness to the innumerable remnants of endless human folly.

Having taken thousands of years to grow and expand to how they are seen in the era of the Imperium, Hive Cities are iconic within human civilization.

It means investigating the original conflict shock.

What's the tissue involved? What's the biological program that's running? What phase are you in? It means looking for tracks and conflict relapses and identifying a biological solution whenever possible and deciding what support the body may need and that support may or not include medical procedures.

The point is not to ignore the body.

The point is to learn enough to make a more informed decision.

So I'm not telling anyone to accept or delay or refuse any sort of treatment.

I'm offering another perspective so you can ask better questions and participate more fully in the decisions about your own body.

I don't think anyone should have to make a life-changing decision without understanding why it's being recommended, what the alternatives are, which biological program are they running, and where are they in the two phases of all disease.

So reducing fear doesn't determine the decision.

[birds chirping] [cow moos] This is the next version of Where Intriages Matter podcast, and today I'm here with Dr. Gordon Rajendram.

He's helped us with our Bio-N research.

We first got some Bio-N about four years ago and threw it on some paddocks to see what happened, and it looked like it worked well in terms of replacing urea.

So I got Gordon down to have a look, and he wandered around and had a look at all the farms that we'd put it on and he said, "Yeah, it looks like it works, but we don't really know." And he said, we got to, uh, do some proper research, scientific trials.

So I suppose you should tell us, or tell everybody what you did to try and see whether or not this Bio-N actually worked.

I'm from AgResearch.

I was there for 22 years.

And so I said to Alan, "Look, the only way we'll know is if we, um, run some trials," just like how I do it when I was in the government, uh, which is replicated trials.

Um, you know, one of the things when I moved back to North America was just shocking to me to see how many clinicians do not know very much about bone grafts.

And just even simple things like what is a xenograft? Why do we use Bio-Oss?

Sure.

The fact that, you know, it's a low substitution rate, AKA non-resorbable.

And, you know, it's a very hard fact that y-you're held to the same standard as a specialist, which means that in implant dentistry world, A, you're gonna need great mentors, but learning all the things you need to learn to be at that level, you know, is, is something that I feel like we're probably a little bit below standard for a lot of people that are not taking proper continuing education courses.

And so, you know, I never wrote any of my books to try and become more well known or anything.

I actually wrote my biomaterial book, um, because I just saw so many people that didn't know, like, what is an allograft? Why do we use fifty-fifty cortical mixes? Why do we use DFDBA? What is the difference, right? Like a lot of clinicians couldn't simply explain to me, you know, what is the difference between FDBA and DFDBA? Where to use one or the other? When do you combine it with Bio-Oss or Xenograft? Like they couldn't ask those things.

And I remember actually, I was, um, I was at the Florida Board and, and just discussing things and somebody was actually at a case and, uh, and they did not know the answers to these very basic questions.

And so today, his work spans research, writing, a lot of podcasts, something that you'll find on his website called The Journey, Farmer's Footprint, products born from living systems.

And now all of this is joined by his book, Biological Elegance, a conversation with AI that has generated what he believes is the clearest articulation of the worldview beneath it all, that health is not something we manufacture.

It is something we participate in.

And the reason that we're holding this conversation now is that Zach is part of a global unity event taking place on October the 17th, online and in person in South Africa.

Health is a journey of life, and it's interconnected relationships that will make that life full, rich, and regenerative, and ultimately full of joy.

And on that way, those relationships will also create all of the necessary heartbreak and disappointment to shatter the expectations of an emotional body until you finally give up on that body and reenter your somatic reality.

And so I call this re-embodiment in the book, uh, Biological Elegance, that just came out, and it's a, a startling Book in the sense that it didn't intend to be a book initially.

It was a conversation that I was having with AI on two potential futures for humankind.

If you flood an ecosystem, you poison it.

Professor Chris Molloy is the Chief Executive Officer of the BioIndustry Association, the BIA, representing and advocating for hundreds of innovative life sciences and biotech companies across the UK and internationally.

Biotech is unstable on purpose.

I think it was it the F-16 or one of the, one of the great American fighter jets that's fundamentally unflyable.

With that breakthrough can survive, grow, and ultimately reach the people who need it.

And that is a question for all of us, for scientists, for entrepreneurs, for investors, for government, and increasingly for regions right across the country.

Because the future of British life sciences cannot be built in just a handful of post codes.

And that's why I'm particularly excited about this conversation as we look ahead to Life Sciences Week twenty twenty-six.

Zach Bush, triple board certified physician and endocrinologist who has spent years at the hospice bedside.

His new book, Biological Elegance, excavates the difference between artificial intelligence and the intelligence of living systems.

Every deathbed story in the end, it's almost inexplicable how much trauma is healed, how many estranged aspects of relationship are healed.

We so often confuse something about life with the felt experience of life.

it would be you.

Zach had no warning that there would be-- he would be leading a hum.

My process of reading the book was pretty emotional, and I want to just share with you a story that I kept coming back to as I was experiencing the book.

So as you mentioned, you've spent a lot of time in hospice medicine.